Literature DB >> 3318613

Salmon calcitonin in the treatment of postmenopausal osteoporosis.

V Fatourechi1, H Heath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3318613     DOI： 10.7326/0003-4819-107-6-923

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

Review 1.  Osteoporosis: clinical features, prevention, and treatment.

Authors:  L A Fleming
Journal:  J Gen Intern Med       Date:  1992 Sep-Oct       Impact factor: 5.128

Review 2.  Estrogen replacement therapy in women at increased risk for breast cancer.

Authors:  R Vassilopoulou-Sellin
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

3.  The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.

Authors:  W A Lee; R D Ennis; J P Longenecker; P Bengtsson
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

4.  Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study.

Authors:  S Ljunghall; P Gärdsell; O Johnell; K Larsson; E Lindh; K Obrant; I Sernbo
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.